The radiopharmaceutical, already approved for SSRT-expressing GEP-NETs, may be a new option in meningioma if future research ...
The firm said it will discuss biomarker results, including a marked decrease in N-acetylaspartate levels and an increase in brain white matter.
Prevail will buy $350,000 worth of shares in Hemogenyx and will serve as a contract research organization for an upcoming clinical trial in pediatric leukemia.
Patients had fewer bleeds after treatment with Beqvez compared to standard treatment, but questions remain about which ...
The FDA expects to issue a decision in the first quarter of 2025, and if the agency grants approval, it will expand the biomarker-eligible population for the drug.
In a draft guidance, the institute did not recommend Orserdu, but is collecting additional data and public comments on this preliminary decision.
The clinical trial testing ATA-200 to treat a type of LGMD caused by mutations in the SGCG gene has already been cleared in Italy and France.
NEW YORK – VieCure said on Monday that it has raised $45 million, which it will put toward advancing its next-generation clinical decision support solution and expanding the scale of its commercial ...
The collaboration will focus on researching the prevalence of ALT in cancer and its genetic drivers to develop new treatments.
Researchers are planning a clinical trial after four metastatic FGFR2 fusion-positive pancreatic cancer patients responded to ...
The companies will initially develop an AI-based test to select patients with CDH17-expressing gastrointestinal cancers for Arbele's Phase I drug trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results